Is CRGX or QYLD a better dividend investment in 2026?

CRGX currently yields 44.74% with a 5% 5-year dividend growth rate. QYLD yields 11.92% with -2.1% growth. The better choice depends on your goal: CRGX offers higher current income.

What is the dividend yield difference between CRGX and QYLD?

CRGX has a forward dividend yield of 44.74% ($2.00/share annually). QYLD yields 11.92% ($2.04/share annually). The yield gap is 32.82 percentage points.

Home › Compare › CRGX vs QYLD

CRGX vs QYLD: Dividend Comparison 2026

CRGX yields 44.74% · QYLD yields 11.92%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 CRGX wins by $273.8K in total portfolio value

INVESTMENT

TIME HORIZON10 years

CRGX

● Live price

44.74%

Share price

$4.47

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$299.2K

Annual income

$55,447.86

Full CRGX calculator →

QYLD

Global X Nasdaq 100 Covered Call ETF

● Live price

11.92%

Share price

$17.15

Annual div

$2.04

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$25.4K

Annual income

$5,659.31

Full QYLD calculator →

Portfolio growth — CRGX vs QYLD

📍 CRGX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	CRGX	QYLD
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, CRGX + QYLD cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

CRGX pays

QYLD pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CRGX

Annual income on $10K today (after 15% tax)

$3,803.13/yr

After 10yr DRIP, annual income (after tax)

$47,130.68/yr

QYLD

Annual income on $10K today (after 15% tax)

$1,013.51/yr

After 10yr DRIP, annual income (after tax)

$4,810.41/yr

At 15% tax rate, CRGX beats the other by $42,320.27/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CRGX + QYLD for your $10,000?

CRGX: 50%QYLD: 50%

100% QYLD50/50100% CRGX

Portfolio after 10yr

$162.3K

Annual income

$30,553.59/yr

Blended yield

18.82%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on QYLD right now

CRGX

Analyst Ratings

Hold

Sell

Consensus: Hold

Price Target

$23.00

+414.5% upside vs current

Range: $7.00 — $34.00

Altman Z

3.1

Piotroski

2/9

QYLD

No analyst data

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CRGX buys

QYLD buys

No recent congressional trades found for CRGX or QYLD in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricCRGXQYLD

Forward yield	44.74% ✓	11.92%
Annual dividend / share	$2.00	$2.04 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$299.2K ✓	$25.4K
Annual income after 10y	$55,447.86 ✓	$5,659.31
Total dividends collected	$232.3K ✓	$27.1K
Payment frequency	quarterly	monthly
Sector	Stock	ETF

Year-by-year: CRGX vs QYLD ($10,000, DRIP)

Year	CRGX Portfolio	CRGX Income/yr	QYLD Portfolio	QYLD Income/yr	Gap
1← crossover	$15,174	$4,474.27	$10,352	$1,192.36	+$4.8K → CRGX
2	$22,582	$6,345.22	$10,830	$1,347.57	+$11.8K → CRGX
3	$32,987	$8,824.93	$11,460	$1,539.07	+$21.5K → CRGX
4	$47,345	$12,048.10	$12,275	$1,777.84	+$35.1K → CRGX
5	$66,819	$16,160.60	$13,323	$2,078.95	+$53.5K → CRGX
6	$92,813	$21,315.98	$14,667	$2,463.34	+$78.1K → CRGX
7	$126,981	$27,671.12	$16,396	$2,960.57	+$110.6K → CRGX
8	$171,251	$35,381.27	$18,631	$3,612.97	+$152.6K → CRGX
9	$227,833	$44,594.79	$21,548	$4,482.15	+$206.3K → CRGX
10	$299,229	$55,447.86	$25,398	$5,659.31	+$273.8K → CRGX

CRGX vs QYLD: Complete Analysis 2026

CRGX — Stock

CARGO Therapeutics, Inc., a clinical-stage biotechnology company, develops chimeric antigen receptor (CAR) T-cell therapies for cancer patients. The company's lead program is CRG-022, an autologous CD22 CAR T-cell product candidate designed to address resistance mechanisms by targeting CD22, an alternate tumor antigen that is expressed in B-cell malignancies. It also develops CRG-023, a tri-specific CAR T product candidate that targets tumor cells with three B-cell antigen targets. The company was formerly known as Syncopation Life Sciences, Inc. and changed its name to CARGO Therapeutics, Inc. in September 2022. CARGO Therapeutics, Inc. was incorporated in 2019 and is headquartered in San Mateo, California.

Full CRGX Calculator →

QYLD — ETF

The Global X Nasdaq 100 Covered Call ETF (QYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe Nasdaq-100 BuyWrite V2 Index.

Full QYLD Calculator →

📬

Get this CRGX vs QYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CRGX vs SCHD CRGX vs JEPI CRGX vs O CRGX vs KO CRGX vs MAIN CRGX vs XYLD CRGX vs JEPQ CRGX vs RYLD

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.